As of the 2026 WADA Prohibited List, semaglutide and other GLP-1 receptor agonists are NOT on the banned substance list
Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management
Safe Disposal Guide Introduction Starting a weight loss journey with a medication like Mounjaro (tirzepatide) is a significant step toward better health
ARA 290 at concentrations exceeding ~1 ng/mL activates the IRR, which functions as a molecular switch to provide long-lasting effects, similar to other effector molecules in the immune response
Appetite suppression, while helpful for weight loss, can lead to challenges in consuming enough protein, vitamins, and minerals
Efficacy Trade-Offs: What the Clinical Evidence Shows Lower cost does not equate to lower efficacy